• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer.

作者信息

Turine G, Peeters A, Hermans C, Eeckhoudt S, Duprez T

机构信息

Department of Neurology, Cliniques Universitaires St-Luc, 10 Avenue Hippocrate 10, 1200, Brussels, Belgium.

Haemostasis and Thrombosis Unit, Division Haematology, Cliniques Universitaires Luc, 10 Avenue Hippocrate 10, 1200, Brussels, Belgium.

出版信息

Acta Neurol Belg. 2017 Sep;117(3):753-755. doi: 10.1007/s13760-017-0751-5. Epub 2017 Jan 30.

DOI:10.1007/s13760-017-0751-5
PMID:28138937
Abstract
摘要

相似文献

1
Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer.达比加群经艾达司珠单抗逆转后行静脉溶栓治疗：成为先驱的时刻。
Acta Neurol Belg. 2017 Sep;117(3):753-755. doi: 10.1007/s13760-017-0751-5. Epub 2017 Jan 30.
2
Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report.用艾达西珠单抗拮抗达比加群后对缺血性卒中进行全身溶栓治疗——病例报告
J Stroke Cerebrovasc Dis. 2016 Aug;25(8):e126-7. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.006. Epub 2016 May 25.
3
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.使用依达赛珠单抗逆转达比加群抗凝后成功进行缺血性卒中的静脉溶栓治疗：一例报告
J Med Case Rep. 2017 Aug 15;11(1):224. doi: 10.1186/s13256-017-1404-2.
4
Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.使用依达赛珠单抗急性逆转达比加群以进行静脉溶栓作为急性卒中治疗
J Clin Neurosci. 2019 Jan;59:355-357. doi: 10.1016/j.jocn.2018.09.027. Epub 2018 Oct 9.
5
Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review.使用依达赛珠单抗逆转达比加群作用后进行静脉溶栓治疗卒中：病例系列研究与系统评价
J Neurol Neurosurg Psychiatry. 2019 May;90(5):619-623. doi: 10.1136/jnnp-2018-318658. Epub 2018 Jul 21.
6
Acute stroke thrombolysis following dabigatran reversal using idarucizumab.使用艾达司珠单抗逆转达比加群后进行急性卒中溶栓治疗。
Neurol India. 2019 Mar-Apr;67(2):568-570. doi: 10.4103/0028-3886.258032.
7
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.德国缺血性卒中或颅内出血情况下idarucizumab拮抗达比加群的病例收集 - 一项全国性病例收集。
Int J Stroke. 2017 Jun;12(4):383-391. doi: 10.1177/1747493017701944. Epub 2017 Mar 24.
8
Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients.idarucizumab 逆转达比加群的作用：4 例急性脑卒中患者的单中心经验。
J Thromb Thrombolysis. 2018 Jul;46(1):12-15. doi: 10.1007/s11239-018-1658-6.
9
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.达比加群抗凝治疗期间发生急性卒中，采用艾达赛珠单抗和静脉注射组织型纤溶酶原激活剂治疗。
J Stroke Cerebrovasc Dis. 2017 Jun;26(6):e102-e104. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.037. Epub 2017 Apr 14.
10
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.依达赛珠单抗逆转达比加群治疗患者抗凝作用的真实世界经验：来自台湾的11例报告
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):e27-e33. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.044. Epub 2017 Nov 6.

引用本文的文献

1
Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke.达比加群酯抗凝逆转剂依达鲁单抗用于缺血性和出血性脑卒中的标准操作流程。
J Thromb Thrombolysis. 2023 Apr;55(3):506-518. doi: 10.1007/s11239-023-02772-3. Epub 2023 Feb 4.
2
Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature.依达赛珠单抗逆转达比加群后的静脉溶栓治疗：文献系统评价
Front Neurol. 2021 Jun 3;12:666086. doi: 10.3389/fneur.2021.666086. eCollection 2021.
3
Two Dabigatran Fast Reversals in a 4-month Period - a Case Report.
4个月内两次达比加群快速逆转——病例报告
Eur J Case Rep Intern Med. 2019 Dec 4;6(12):001311. doi: 10.12890/2019_001311. eCollection 2019.
4
Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations.日本抗凝患者卒中溶栓共识指南：对其他人群的应用
J Stroke. 2018 Sep;20(3):321-331. doi: 10.5853/jos.2018.01788. Epub 2018 Sep 30.
5
Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis.艾达赛珠单抗（Praxbind）逆转直接凝血酶抑制剂达比加群作用的证据：RE-VERSE AD全队列分析后的综述
P T. 2017 Nov;42(11):692-698.
6
Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.达比加群酯治疗的急性缺血性脑卒中患者应用依达鲁单抗溶栓：现有证据的系统评价。
CNS Drugs. 2017 Sep;31(9):747-757. doi: 10.1007/s40263-017-0460-x.
7
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.使用依达赛珠单抗逆转达比加群抗凝后成功进行缺血性卒中的静脉溶栓治疗：一例报告
J Med Case Rep. 2017 Aug 15;11(1):224. doi: 10.1186/s13256-017-1404-2.